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Abstract 15 
With resistant bacteria on the increase, there is a need for new combinations of antimicrobials 16 
/ biocidal agents to help control the transmission of such microorganisms. Particulate forms of 17 
graphite, graphene oxide (GO) and metal-hybrid compounds (silver-graphene oxide (AgGO) 18 
and zinc oxide graphene oxide (ZnOGO)) were fabricated and characterised. X-Ray diffraction 19 
and Diffuse Reflectance Infrared Fourier Transform Spectroscopy demonstrated the 20 
composition of the compounds. Scanning Electron Microscopy and Energy Dispersive X-Ray 21 
Spectroscopy determined the compounds were heterogeneous and irregular in shape and size 22 
and that the level of silver in the AgGO sample was 57.9 wt.% and the ZnOGO contained 72.65 23 
wt. % zinc. The compounds were tested for their antimicrobial activity against four prominent 24 
bacteria; Escherichia coli, Staphylococcus aureus, Enterococcus faecium and Klebsiella 25 
pneumoniae. AgGO was the most effective antimicrobial (Minimum inhibitory concentration 26 
E. coli / Enterococcus faecium 0.125 mg mL-1; S. aureus / K. pneumoniae 0.25 mg mL-1). The 27 
addition of Ag enhanced the activity of GO against the bacteria tested, including the generally 28 
recalcitrant K. pneumoniae and Enterococcus faecium. These findings demonstrated that GO-29 
metal hybrids have the potential to be utilised as novel antimicrobials or biocides in liquid 30 
formulations, biomaterials or coatings for use in the treatment of wounds where medically 31 
relevant bacteria are becoming increasingly resistant. 32 
Keyword: Antimicrobials; graphene oxide, biocide; ESKAPE; nano / micro particles; 33 
pathogens 34 
1. Introduction  35 
Concerns about bacterial resistance from community-acquired and food-borne pathogens has 36 
been growing for a number of years at both national and international levels. Several Gram-37 
positive and Gram-negative bacteria including Escherichia coli, Klebsiella pneumoniae, 38 
Enterococcus faecium and Staphylococcus aureus are currently considered as emergent global 39 
pathogens, which pose a huge global health problem (Boucher et al., 2009).  40 
Metals have been used for decades to treat various infectious diseases, and their antimicrobial 41 
efficacies are now being re-evaluated owing to the emergence of resilient pathogens. A 42 
particular interest has emerged particularly in the use of these compounds for topical / 43 
therapeutic use as well as for disinfection to prevent the adhesion and transmission of bacterial 44 
species. Silver is one of the most widely investigated metals for antimicrobial applications, and 45 
is being used in a number of medical purposes including catheters, biomaterials and wound 46 
dressings. Zinc oxide (ZnO) is used in such applications as food packaging (Tayel et al., 2011), 47 
textiles (Velmurugan et al., 2016), as antimicrobials (Deokar et al., 2016), and in wound 48 
dressings (Chaturvedi et al., 2016). Nanoparticles are interesting in that they can be synthesized 49 
with a high surface area to volume ratio and with unusual morphologies that contain sharp 50 
edges and corners. Graphite and the graphene derivatives have traditionally been used in 51 
electrochemistry, from applications in energy technologies, such as batteries and fuel cells and 52 
they have also been used in an array of functional composites (Unwin, et al., 2016). Work has 53 
recently suggested that the graphene family of compounds also possess antimicrobial properties 54 
(Liu et al., 2011; Wang et al., 2012). By combining the antimicrobial activity of metals together 55 
with the physical effect of GO on the bacterial cell walls, it may be hypothesised that the 56 
antimicrobial activity of graphene products may be increased.  57 
A number of disinfectants and antiseptics have been reported to be showing signs of becoming 58 
less effective so there is a need for the development of novel microbicides due to the current 59 
limitations (Russel and Chopra, 1990; Jennings et al 2015). Transmission and infection 60 
problems due to bacterial adhesion to surfaces can be mitigated in part by the development of 61 
alternative antimicrobial sources / biocides. The aim of this work was to determine if metal-62 
GO hybrid compounds demonstrated increased antimicrobial efficacy compared to graphite 63 
and GO, against a range of bacteria. The development of such alternative antimicrobial actives 64 
may prove beneficial for use in such formulations such as biocidal, disinfecting or topical 65 
antimicrobials or cleaning agents or for incorporation into biomaterial coatings. 66 
2. Materials and Methods 67 
2.1 Synthesis of compounds and characterisation 68 
For the synthesis of the compounds, all chemicals (analytical grade or higher) were used as 69 
received from Sigma-Aldrich (UK) without any further purification and all solutions were 70 
prepared with deionised water of resistivity not less than 18.2 MΩ cm. Synthetic graphite 71 
powder was commercially obtained from Gwent Group (Pontypool, UK).  72 
Graphene oxide (GO) was synthesized by the Hummers method via the oxidation of synthetic 73 
graphite (Hummers Jr and Offeman, 1958). Graphite flakes (5 g) and NaNO3 (2.5 g) were 74 
combined in 115 mL of H2SO4 (conc.) and stirred for 30 min. Whilst kept in an ice bath (<5 75 
°C), KMnO4 (15.0 g) was gradually added to the suspension and the rate of addition was 76 
controlled to keep the reaction temperature below 15 °C. The mixture was heated to 35 °C for 77 
a 30 min period and underwent continuous stirring producing a brown paste. A further dilution 78 
was made by adding 250 ml of water to the mixture and the temperature was increased to 70 79 
°C for 15 min. The resultant mixture was diluted by adding H2O until a final volume of 1 L 80 
was obtained. Finally, the solution was treated with 15 mL of H2O2 (30 % w/w) to terminate 81 
the reaction, at which stage the solution became yellow in appearance. For purification, the 82 
mixture was filtrated and the obtained solid was washed thoroughly with Milli Q water several 83 
times in order to avoid sulphate contamination. After purification, the powder was dried at 60 84 
°C during 48 h.  85 
In the preparation of the AgGO, a sonochemical reduction method was utilised (Anandan and 86 
Muthukumaran, 2015). Following preparation of the GO, 0.5 g was added to 150 mL of 87 
ethylene glycol and sonicated for 30 min. In a separate vesicle, 1.0 g of silver nitrate was added 88 
to 20 mL of ethylene glycol and sonicated for 30 min. The silver nitrate dispersion was added 89 
drop-wise to the GO solution whilst undergoing sonication for 30 min to produce a 90 
homogeneous mixture. Finally, 50 mL of 0.1 M NaBH4 was added to the resultant AgGO 91 
mixture and a further 30 min of sonication was performed. The product was purified with 92 
repeated steps of H2O and ethanol washing, after which the solution was dried at 50 °C. 93 
The ZnOGO was fabricated by dissolving 5.0 g GO in 200 mL of N, N,-dimethylformamide 94 
(DMF), along with 20 ml of 1 M zinc acetate dihydrate (pH of 6.5). The homogeneous solution 95 
was heated to 60 °C and was stirred continuously for 120 min, after which the solution was 96 
heated to 250 °C. Following solvent evaporation, partial ZnO / ZnOHGO was produced. The 97 
resulting dried product was collected and ground in an agate mortar prior to being annealed at 98 
450 °C for 120 min within atmospheric conditions to obtain the final ZnOGO product (Liu et 99 
al., 2012). 100 
2.1.1 Preparation of compounds for testing  101 
For the analysis of the fabricated compounds, 20 mg of each test compound was added to 20 102 
mL of sterile distilled water. The samples were vortexed for 10 s and immediately 10 µL of 103 
prepared sample was pipetted onto a 10 mm x 10 mm polished silicon wafer (Montco Silicon 104 
Technologies, USA) and air dried for 30 min. The samples were stored at room temperature, 105 
in desiccators until use. 106 
2.1.2 X-Ray Diffraction (XRD)  107 
In order to identify the crystal phase of the compounds, X-Ray Diffraction (XRD) was 108 
performed using a PANalytical X'pert powder diffraction platform. Nickel filtered copper Kα 109 
radiation (l = 1.54 Å) was used, with an anode voltage of 40 kV an anode current of 30 mA. A 110 
reflection transmission spinner stage (15 rpm) was implemented to hold the powder samples. 111 
The XRD parameters were step size: 0.13; sample: powder; slit (antiscatter) size: 1/4°. The 2q 112 
range was set between 10° and 100°, in correspondence with literature ranges associated with 113 
the characterised samples (Li et al., 2007; Zhou et al., 2007; Kumar et al., 2013; Chowdhuri et 114 
al., 2015; Liu et al., 2016).  Additionally, to ensure well-defined peaks, an exposure of 50 s per 115 
2q step was implemented. 116 
2.1.3 Diffuse Reflectance Infrared Fourier Transform Spectroscopy (DRIFTS)  117 
Diffuse Reflectance Fourier Transform Infrared Spectroscopy (DRIFTS) was carried out using 118 
a Spectra-Tech DRIFTS cell fitted in a Thermo – Nicolet Nexus FTIR spectrophotometer. The 119 
instrument was thoroughly purged (30 L / min) with CO2 and water-free air, produced using a 120 
Balaston purge gas generator. All samples were diluted to ca. 5 % wt. in finely ground KBr 121 
(Sigma, UK). The samples were used as received, with no further grinding. The sample was 122 
folded into the pre-ground KBr using a micro-spatula. The micro-sampling cup was over-filled 123 
slightly and the cup dropped from a height of 1 cm onto the bench in order to shake off the 124 
excess mixture whilst at the same time, produce a slightly domed and naturally randomised, 125 
surface of KBr diluted sample. The same batch of ground KBr was used as the background. 126 
The background and sample spectra were made up of 164 scans with resolution set to 4 cm-1. 127 
As the sample was diluted with KBr there were no specular reflection components so a blocker 128 
was not used. Spectra were plotted in absorbance (Liauw, 2003). 129 
2.1.4 Scanning Electron Microscopy (SEM) and Energy Dispersive X-Ray Spectroscopy (EDX) 130 
In order to determine the shape, size and atomic elemental weight of the compounds, the 131 
samples were fixed to stubs using carbon tabs (Agar, UK). Scanning Electron Microscopy (Carl 132 
Zeiss Ltd.) was carried out using a Supra 40VP SEM with SmartSEM software. Energy 133 
Dispersive X-Ray (EDAX Inc.) was carried out using an Apollo 40 SDD system with Genesis 134 
software. 135 
2.2 Microbiology and antibacterial testing  136 
2.2.1 Stock cultures of bacteria 137 
In preparation for the antimicrobial assays, stock cultures of S. aureus NCTC 4137, K. 138 
pneumoniae NCTC 9633 or E. coli NCTC 10418 were inoculated onto nutrient agar (NA) or 139 
nutrient broth (NB) and incubated at 37 °C for 24 h. Stock cultures of Enterococcus faecium 140 
NCTC 7171 were cultured onto Columbia blood agar with horse blood in a 5 %, Brain heart 141 
infusion agar (BHIA) (Oxoid, UK) or brain heart infusion broth (BIHB) and incubated in 5 % 142 
CO2 for 24 h at 37 °C. All medias were obtained from Oxoid (UK).  143 
2.2.2 Preparation of microbiological cultures 144 
Ten millilitres of appropriate broth was inoculated with a single colony of bacteria and 145 
incubated overnight according to the above conditions. Following incubation, cells were 146 
harvested at 567 × g for 10 min and washed once, re-suspended in sterile distilled water, 147 
vortexed for 30 s, and then centrifuged again at 567 × g for 10 min. The inocula were examined 148 
in a spectrophotometer at 540 nm and compared against a blank of sterile distilled water to 149 
determine their optical density. They were then diluted accordingly and quantified using serial 150 
dilutions. The cell concentrations corresponded to; E. coli 4.20 × 108, S. aureus 1.30 × 108, 151 
Enterococcus faecium 3.95 × 108 and K. pneumoniae 2.82 × 108 colony forming units per mL 152 
(CFU / mL). 153 
2.2.3 Zones of inhibition  154 
The zones of inhibition assays were performed to test the antimicrobial efficacy of each 155 
individual compound (n = 24). One hundred microliters of prepared cell suspension was 156 
pipetted and spread across the surface of the agar. Three equal wells (8 mm diameter) were cut 157 
out of the each agar plates. To each of the wells, 100 µL of suspended compound was added. 158 
The plates were incubated in the appropriate air conditions and temperature for 24 h. Following 159 
incubation, the zones of inhibition was measured in mm from four sides of each well to 160 
determine an average mean value (n = 24).  161 
2.2.4 Minimum inhibitory concentrations (MIC) 162 
The minimal inhibitory concentration (MIC) is defined as the lowest concentration of 163 
antimicrobial to prevent bacterial growth (Russel and Chopra, 1990). One millilitre of triphenyl 164 
tetrazolium chloride (TTC) blue metabolic dye (Sigma-Aldrich, UK), was added into 9 mL of 165 
the cell suspension so that the working concentration of the dye was 0.15 % w/v. To determine 166 
the MIC, the samples and bacteria were added to a 96 well flat-bottomed microtiter plate (MTP) 167 
and a serial dilution method used across the plate. A bacterial suspension without any 168 
compound (positive control) and un-inoculated broth (negative control) was included. After 169 
incubation, the MIC was taken as lowest concentration that inhibited the visible growth of the 170 
bacteria by comparison with the controls. Growth was indicated by a change of colour in the 171 
well to dark blue / purple.  172 
2.3.5 Minimum Bactericidal Concentration (MBC) 173 
The MBC is defined as the lowest concentration required to completely inactivate the inoculum 174 
at a given time (Humphreys et al., 2011). To perform the MBC assays, 25 µL was sampled and 175 
pipetted onto agar plates from the MIC well that showed no growth and also from the first well 176 
that showed growth and incubated overnight in appropriate conditions. After incubation, the 177 
lowest concentration well sample that showed no growth on the agar plate was determined to 178 
be the MBC for that test sample. 179 
2.3.6 Statistical analysis 180 
Statistical tests were carried out using a two tailed distribution t-test with two sample 181 
homoscedastic variance. Results were reported as mean ± standard error or percentage and any 182 
observed differences were considered significant at a p < 0.05. 183 
3. Results  184 
3.1 Particle characterisation 185 
In order to assess the antibacterial activity of four compounds, graphite, GO, AgGO and 186 
ZnOGO, the compounds and hybrid molecules were firstly obtained or synthesized, then 187 
characterised and then tested using well-established antibacterial assays. The XRD patterns 188 
relating to the graphite powder produced the expected characteristic diffraction peaks at 2θ = 189 
26.6°, 44.7° and 54.6°, corresponding to the (002), (101) and (004) diffraction peaks of graphite 190 
powder respectively (Fig. 1a and aʹ). XRD (Fig.1 aʹ) plotted over a narrower 2θ range and with 191 
a finer counts scale, showed some disordered material as evidenced by the wide peak between 192 
ca. 7 and 17° and by a characteristic ‘sharp’ peak was evident at 2θ = 11.8° (Fig. 1b). The 193 
composition of the GO sample was confirmed as corresponding to the (002) diffraction peak 194 
of disordered GO. Application of the Bragg equation to the reflection peak angles, revealed 195 
that the interplanar distance increased from 0.35 nm in graphite to 0.75 nm in graphene oxide. 196 
For the latter, EDX gave 54.6 wt.% C and 45.3 wt.% O (O/C ratio = 0.83), whilst the former 197 
(graphite) had an oxygen content of only 8.9 wt.%, with all of the remainder being carbon 198 
(Table 1). 199 
The ZnOGO was confirmed by XRD to have a high concentration of ZnO (Fig. 1c). Diffraction 200 
peaks were evident at 2θ = 32.2°, 34.8°, 36.7°, 48.0°, 57.0°, 63.3°, 66.8°, 69.5° and 72.9° which 201 
corresponded to the (100), (002), (101), (102), (110), (103), (112), (201) and (004) crystalline 202 
planes of ZnO, respectively (Liu et al., 2012). EDX revealed that the ZnOGO contained C (8.60 203 
wt.%), O (18.75 wt.%) and Zn (72.65 wt.%). Due to the low level of carbon in ZnOGO, the 204 
(002) reflection for GO (centred at ca. 10°) (Fig. 1cʹ) was very weak. The ZnOGO was light 205 
grey in colour thus confirming the presence of carbon in the sample.  206 
Following analysis of the AgGO, the diffraction peaks occurred at 2q = 38.7°, 44.9°, 65.0° and 207 
77.9° (Fig. 1d). These peaks corresponded to the (111), (200), (220) and (311) crystallographic 208 
planes of face-centred cubic silver. A small amount of Ag2O was present as evidenced by the 209 
corresponding (110) and (111) reflections at 28.4° and 3332.8° respectively. The (002) 210 
reflection of the GO was significantly attenuated (Fig. 1d) and shifted from 11.8° to 10° (d(002) 211 
= 0.86 nm). There was also a broad reflection peak over the range 12° and 18°, with two small 212 
peaks centred at 15° and 20° (Fig. 1dʹ) whereby corresponding d values were 0.60 nm and 0.44 213 
nm, respectively, indicating the presence of disordered structures. 214 
Diffuse Reflectance Infrared Fourier Transform Spectroscopy (DRIFTS) was used to further 215 
characterise the compounds. Overlaid DRIFTS spectra of the 4000 cm-1 – 2000 cm-1 region for 216 
the graphite, GO and AgGO demonstrated that the DRIFTS spectrum of graphite (Fig. 2a)  was 217 
largely featureless as expected, though there was a small and negative hydrogen bonded OH 218 
stretching peak which was due to there being slightly more moisture in the background than 219 
the sample. The size and position of this band did not hinder interpretation of this spectral 220 
region for GO or AgGO. Graphene oxide (Fig. 2b) showed the expected broad envelope of 221 
hydrogen bonded OH stretching vibrations from 3700 cm-1 to 2500 cm-1, together with some 222 
OH bands at 3650 cm-1 that appeared to be much less involved in hydrogen bonding. Interaction 223 
of the GO with the silver (Fig. 2c) appeared to remove the latter OH stretching band and 224 
generally attenuated the hydrogen bonded OH stretching within the region above 3350 cm-1. 225 
There were some small aliphatic C-H stretching vibrations at 2946 cm-1 (asymmetric) and 2877 226 
cm-1 (symmetric). The 2000 cm-1 to 400 cm-1 region of the same three samples demonstrated 227 
that the graphite spectrum (Fig. 3a) was again featureless apart from a small negative peak at 228 
1650 cm-1 which could be assigned to an O-H bend of water, indicating again that there was 229 
slightly more moisture in the background than the sample; this peak did not interfere with 230 
interpretation. The GO featured all the expected peaks (Fig. 3b); carbonyl stretching (1738 cm-231 
1); skeletal aromatic C=C vibrations (1615 cm-1); C-OH stretching (1356 cm-1); C-O-C 232 
stretching (1225 cm-1); C-O stretching (1056 cm-1); aromatic C-H bending (849 cm-1). The 233 
AgGO (Fig. 3c) also featured the same absorption bands but with the following significant 234 
differences: carbonyl stretching, skeletal aromatic C=C vibrations and C-O-C stretching 235 
vibrations were all red-shifted by 10 cm-1, 29 cm-1 and 5 cm-1, respectively. Furthermore, the 236 
C-O vibration was split and consisted of a blue shifted component (1078 cm-1) and a red shifted 237 
component (1037 cm-1) (Table 2).  238 
Overlaid spectra of the synthesised ZnO and ZnOGO demonstrated in both spectra, carbon 239 
dioxide absorption at 2350 cm-1 (Fig. 4) and carbonate absorptions at ca. 1580 cm-1 and 1380 240 
cm-1 (Fig. 5). SEM showed that the compounds were heterogeneous and irregular in size (Table 241 
3) and shape (Fig. 6). Graphite (Fig. 6a) had a flattened, irregular, random orientation, 242 
fractured, sheet like morphology with sharp, cleaved edges (0.10 µm – 25.7 µm). Graphene 243 
oxide (Fig. 6b) was composed of aggregated creased platelets (0.20 µm – 20.0 µm). The 244 
ZnOGO (Fig. 6c) consisted of numerous aggregated nanoparticles and / or nanoparticles 245 
covering micron-sized particles (0.05 µm – 30.0 µm). AgGO (Fig. 6d) was similar to GO in 246 
appearance; creased aggregated platelets with a random scattering of nanoparticles (possibly 247 
silver and / or silver oxide) (0.01 µm- 13.0 µm).  248 
3.2 Microbiological analysis 249 
Zones of inhibition assays were carried out against Gram-negative E. coli and K. pneumoniae 250 
and Gram-positive S. aureus and Enterococcus faecium (Fig. 7). Following the zone of 251 
inhibition assays, all the compounds demonstrated antimicrobial activity against E. coli and all 252 
the GO-containing compounds demonstrated antimicrobial activity against S. aureus. Graphite 253 
was only effective against E. coli and thus demonstrated a significantly greater antimicrobial 254 
efficacy than GO or ZnOGO against this bacteria (p > 0.05). The most effective antimicrobial 255 
overall against the bacteria using zones of inhibition was AgGO which provided the greatest 256 
zones of inhibition against E. coli (4.48 mm) and S. aureus (4.50 mm).   257 
The MIC results demonstrated that against E. coli all the compounds were effective at 258 
concentrations of 0.125 mg mL-1. Against S. aureus, graphene oxide was the most effective 259 
(0.125 mg mL-1) whilst AgGO was the most effective against Enterococcus faecium (0.125 mg 260 
mL-1). K. pneumoniae was again the most difficult bacteria to inhibit. However, the ZnOGO 261 
and AgGO compounds demonstrated statistically significant inhibitory effects compared to the 262 
graphite and GO compounds against K. pneumoniae at concentrations of 0.25 mg mL-1 (p > 263 
0.05). MBCs demonstrated that against E. coli, ZnOGO and AgGO were the most effective at 264 
0.125 mg mL-1. GO, ZnOGO and AgGO were all effective against S. aureus at a concentration 265 
of 0.25 mg mL-1 whilst AgGO was the most effective against Enterococcus faecium (0.125 mg 266 
mL-1) (Fig. 8b).  It was demonstrated that as with the other assays, K. pneumonia was the most 267 
difficult bacteria to eradicate, demonstrating the greatest MBC values. However, AgGO was 268 
the most effective hybrid compound against this bacteria at a concentration of 0.25 mg mL-1.  269 
4. Discussion 270 
4.1 Characterisation of compounds 271 
The XRD patterns relating to the graphite powder produced the expected characteristic 272 
diffraction peaks (Peng et al., 2013). The composition of the GO sample was confirmed 273 
(Chowdhuri et al., 2015) and  it was evident that the (002) reflection had shifted to a lower 274 
angle and was of much lower intensity, relative to the same reflection in graphite. These 275 
observations are well established and indicate the formation of pendent oxygen containing 276 
functional groups on the top and bottom surfaces of the basal planes that increase the 277 
interplanar distance; this resulted in the shift of the (002) reflection to a lower angle 278 
demonstrating significantly decreased stacking uniformity (resulting in reduced reflection 279 
intensity). This is consistent with the DRIFTS data that indicated prolific functionalisation. The 280 
XRD also demonstrated disruption of the relatively ordered stacking of GO platelets due to 281 
non-uniform intercalation by the ZnO nanoparticles and / or coverage of the ZnO particles by 282 
GO, which may have contributed to a reduced intensity of the reflection (Chowdhuri et al., 283 
2015). The AgGO peaks corresponded to crystallographic planes of face-centred cubic silver 284 
(Zhou et al., 2007). A small amount of Ag2O was present
 but as the atomic radius of silver is 285 
0.17 nm, it is conceivable that individual silver atoms may have intercalated the platelets 286 
(Dhoondia and Chakraborty, 2012). The attenuation of the (002) reflection indicated that the 287 
otherwise relatively regular stacking of GO had probably been disrupted by non-uniformly 288 
sized Ag nanoparticles between the GO platelets. It is also plausible that the GO may form a 289 
coating on the Ag nanoparticles (Oo, 2007; Das et al., 2011; Ma et al., 2011). The level of 290 
silver (by EDX) in the sample was 57.9 wt.%; a mix of GO intercalation by Ag nanoparticles 291 
and GO coating of Ag nanoparticles may therefore be likely. The level of carbon (20.3 wt.%) 292 
can be accommodated by the proposed structures of the hybrid. The oxygen in the Ag2O will 293 
have contributed to the amount of overall oxygen identified in the sample (21.8 wt %). 294 
The DRIFTS spectrum of graphite was largely featureless as expected. GO showed the 295 
expected broad envelope of hydrogen bonded OH stretching vibrations. AgGO appeared to 296 
remove the latter OH stretching band and generally attenuated the hydrogen bonded OH 297 
stretching. This may be due to the interaction of the silver with weakly hydrogen bonded OH 298 
groups (phenolic OH and other OH) of the GO. The more general attenuation of the hydrogen 299 
bonded O-H bands, within the region above 3350 cm-1, may be related to reduced water content 300 
in the AgGO and / or interaction of the silver with the hydrogen bonded OH groups of the GO. 301 
There were some small aliphatic C-H stretching vibrations. These may be due to residual 302 
ethylene glycol from the compound synthesis and to a lesser extent, residual ethanol from 303 
washing. The C-O vibration was split and consisted of a blue shifted component (1078 cm-1) 304 
and a red shifted component (1037 cm-1). These observations indicated a significant interaction 305 
of the GO platelets with the silver. The latter is further supported by a blue shift in the aromatic 306 
C-H bending and C-OH stretching band. Interaction of the silver with carbonyl species and 307 
with the residual p-electrons in the GO would lead to the observed red shifts as the bond 308 
vibration was damped by interaction with the electron orbitals of silver atoms. This would also 309 
result in shortening of the aromatic C-H bonds and phenolic and carboxylic acid C-OH bonds, 310 
hence giving rise to the observed blue shift. The split in the C-O vibration indicated silver 311 
interactions having varying effects on the different ether linkages in the GO. It may be 312 
speculated that the ether groups at the platelet edges would be blue shifted and those actually 313 
pendant from a platelet surface may be red-shifted due to their interaction with the silver atoms. 314 
These observations are supported by the XRD data which indicated that the usual relatively 315 
ordered structure of the GO had been destroyed by its interaction with the silver. It may be that 316 
the silver atoms / particles had intercalated the layers resulting in highly non-uniform stacking. 317 
This would lead to the significantly attenuated and broadened GO related reflections in the 318 
XRD data for the AgGO. 319 
The features observed using the DRIFTS analysis were expected in the ZnO that had been 320 
synthesised via this route since the carbonate and carbon dioxide would be decomposition 321 
products of the starting materials (Selim et al., 2015). The carbonate would have been 322 
converted to CO2 as the annealing temperature increased, resulting in the CO2 becoming 323 
trapped within the structure.  Interestingly, the OH stretching bands were more intense in the 324 
ZnOGO, and it may be that these were related to the GO, though the associated carbonyl and 325 
C-O bands could not be resolved. This may be explained by the strong association between the 326 
GO and ZnO resulting in attenuation of these vibrations. The GO may have coated the surface 327 
of the synthesised ZnO particles and / or could have become interleaved within the synthesised 328 
ZnO structures. In either case, the relatively ordered stacking of the GO platelets had become 329 
disrupted. The XRD data supports the latter proposition. The other area of interest in these 330 
spectra was the Zn-O bending vibrations at ca. 440 and 520 cm-1. In the ZnOGO, the ZnO band 331 
at 520 cm-1 was stronger than in the synthesised ZnO (Fig. 5b). To the authors knowledge, such 332 
observations have not been reported elsewhere, but it may be related to a difference in the 333 
chemical environment and possibly due to the interactions with the GO. 334 
SEM demonstrated that the compounds were heterogeneous and irregular in size and shape. 335 
The ZnOGO particles had the greatest size range (0.05 µm – 30 µm), whereas AgGO and 336 
ZnOGO had the smallest sized particles (0.01 µm and 0.05 µm respectively) demonstrating the 337 
availability of both nano- and micron sized particles. 338 
4.2 Microbiology 339 
The zone of inhibition assays demonstrated that none of the compounds had any effect against 340 
Enterococcus faecium or K. pneumoniae. This may be due to the zone of inhibition method 341 
being carried out using a semi-solid media; this combined with the thick capsule of the K. 342 
pneumoniae and the insusceptible nature of the Enterococcus faecium may have resulted in the 343 
reduced antimicrobial effect demonstrated. Further, the bacteria in this method were growing 344 
on the agar in colonies. These ‘communities’ of bacteria may have been more resistant to the 345 
antimicrobial effects of the compounds, similar to the effects observed when bacteria form 346 
biofilms (Gilbert et al., 2002) rather than what was observed when the bacteria are in planktonic 347 
form as in the MIC and MBC.  348 
Work by others has demonstrated the antibacterial activities of graphite and graphite oxide 349 
towards E. coli and it was found that a GO dispersion demonstrated an 89.7% of loss viability 350 
at 40 mg mL-1 (Liu et al., 2007). In our work, we demonstrated an antimicrobial activity of GO 351 
at much lower concentrations against the four bacterial strains tested (MIC = 0.125 mg mL-1 – 352 
0.5 mg mL-1; MBC = 0.25 mg mL-1 – 0.5 mg mL-1). Work by Xie et al. (2011) demonstrated 353 
the MIC of ZnO nanoparticles for Escherichia coli O157:H7 was found to be 0.4 mg mL-1. In 354 
comparison with our work, ZnOGO was the most antimicrobial compound against E. coli with 355 
an MIC at the lower concentration of 0.125 mg mL-1. However, the E.coli used in our study 356 
was a different strain. The ZnOGO was also inhibitory against S. aureus, Enterococcus faecium 357 
and K. pneumoniae at a MIC of 0.25 mg mL-1. GO and AgGO were also effective against S. 358 
aureus and Enterococcus faecium at concentrations of 0.125 mg mL-1. Work by others also 359 
demonstrated that the MIC for ZnO nanoparticles was 1.5 mg mL-1 and 3.1 mg mL-1 against S. 360 
aureus and E. coli respectively demonstrating that in some cases our ZnOGO compound was 361 
more effective than the antimicrobial action of ZnO alone used in other studies (Franklin et al., 362 
2007; Azam et al., 2012). The MIC against Enterococcus faecium and K. pneumoniae was 363 
optimal with the AgGO hybrid compound. ZnOGO also demonstrated the same MIC as AgGO 364 
against K. pneumoniae.  365 
Results from the MBC assays demonstrated that K. pneumonia was the most difficult bacteria 366 
to eradicate. Work by others using MBC assays with 18 nm nanoparticles of ZnO demonstrated 367 
that the concentration of particles required against E. coli was 0.018 mg mL-1 and 0.016 mg 368 
mL-1 against S. aureus (Xie et al., 2011). However, in contrast with their results, our compounds 369 
required greater concentrations in order to obtain the MBC. This may be explained by the 370 
particle size of our compounds being generally larger. It has been suggested that the smaller 371 
the size of the compounds, the greater the antimicrobial activity of the agent, however 372 
contradictory results have been reported where size dependent effects were not found to 373 
influence the antimicrobial activity of ZnO (Chen et al., 2014). 374 
The antimicrobial activity of the hybrid compounds may be explained in part by either the 375 
shape of the compound particles or by the percent of active facets. The atomic structure of the 376 
particle surface will affect its interaction with the bacterial cells (Selim et al., 2015). It is 377 
expected that the adsorption of atoms and molecules as a result of the interaction of the particles 378 
with the environment will be altered on the different planes, thus the difference in the atomic 379 
structure of the particles may result in a difference in their surface properties that could affect 380 
their interaction with the bacteria, leading to different antimicrobial efficacies (Pal et al., 2007).  381 
It has been suggested that high density facets with (111) faces exhibit greater amounts of 382 
antimicrobial activity (Pal et al., 2007). This is in agreement with our work since the AgGO 383 
demonstrated the greatest numbers of (111) planes. Combined with the shape of the 384 
compounds, these crystal structures can influence their mechanism of bacterial internalisation 385 
of the cell wall (Sirelkhatim et al., 2015).  386 
Work by Liu et al. (2011) focused on the interactions of GO and graphite on bacterial 387 
membranes against Escherichia coli. In agreement with our results, they showed that a GO 388 
dispersion had a greater amount on antibacterial activity than graphite. GO and graphite are 389 
thought to confer antimicrobial activity due to membrane stress on the bacterial cells induced 390 
by the sharp edges of the compounds (Liu et al., 2011; Chen et al., 2014). An interesting fact 391 
that was evidenced in this work was that the type of antimicrobial assay used produced a range 392 
of results and thus it may be concluded that the use of one antimicrobial assay to determine the 393 
efficacy of compounds is not sufficient. Further, the type of antimicrobial assay used should be 394 
selected in line with the proposed final application of the antimicrobials.  395 
Following each of the antimicrobial tests, AgGO demonstrated the greatest overall 396 
antimicrobial efficacies. E. coli was the most susceptible to the compounds followed by S. 397 
aureus, Enterococcus faecium and finally K. pneumoniae. This can be explained in part by the 398 
nature of the microorganisms physiology. The Gram-negative microorganisms E. coli and K. 399 
pneumoniae are surrounded by an outer and inner cell membrane which have between them a 400 
thin layer of peptidoglycan. However, K. pneumoniae also has a large polysaccharide capsule 401 
surrounding the bacterial cell; in addition, this capsule acts as a barrier to antimicrobial agents 402 
(Highsmith and Jarvis, 1985). S. aureus and Enterococcus faecium are Gram-positive bacteria 403 
that have a cell membrane, chiefly composed of thick peptidoglycan. However, Enterococci 404 
are intrinsically more resistant to many antibiotics since unlike acquired resistance and 405 
virulence traits which are usually encoded by plasmids or transposon elements, their intrinsic 406 
resistance is based on chromosomal genes (Huycke et al., 1998). Further, a number of 407 
antibiotics demonstrate bacteriostatic but not bactericidal activity against Enterococcus 408 
faecium bacteria (Huycke et al., 1998). Thus, the use of AgGO against these two resilient 409 
bacteria may be an important step in maintaining the hygienic status of areas into which the 410 
molecule is applied or incorporated. 411 
5. Conclusions 412 
ZnOGO and AgGO hybrid compounds were successfully produced and characterised. AgGO 413 
was the most effective antimicrobial and enhanced the activity of GO. The effect of the 414 
compounds on the bacteria did not relate to the Gram-positive or Gram-negative structures of 415 
the bacteria but rather, was due to their microorganisms overall physiology. GO-metal hybrids 416 
have the potential to be beneficially utilised as novel antimicrobials or biocides in settings 417 
where bacteria are becoming increasingly problematic.  418 
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  520 
 521 
Fig. 1 X-Ray Diffraction patterns for; (a) graphite, (b) graphene oxide (GO), (c) zinc oxide – graphene 522 
oxide hybrid (ZnOGO) and (d) silver – graphene oxide hybrid (AgGO). Note the individual peak heights 523 
– patterns have been compressed to fit. In the right hand stack, patterns aʹ to dʹ correspond to those 524 
in the left stack but are plotted over a narrower 2q range on common counts scale (with Y-shifting for 525 
presentation purposes). ZnOGO and AgGO have 50 x boosted counts and are Y-shifted for presentation 526 
purposes.  527 
 528 
                            529 
Fig. 2 DRIFTS spectra (4000 cm-1 to 2000 cm-1) of (a) graphite, (b) graphene oxide (GO) and (c) silver – 530 
graphene oxide hybrid (AgGO). 531 
  532 
 533 
 534 
Fig. 3 DRIFTS spectra (2000 cm-1 to 500 cm-1) of (a) graphite, (b) graphene oxide (GO) and (c) silver – 535 
graphene oxide hybrid (AgGO). 536 
  537 
  538 
Fig. 4 DRIFTS spectra (4000 cm-1 to 2000 cm-1) of (a) synthesised zinc oxide (ZnO), (b) synthesised zinc 539 
oxide – graphene oxide hybrid (ZnOGO). 540 
  541 
 542 
Fig. 5 DRIFTS spectra (2000 cm-1 to 400 cm-1) of (a) synthesised zinc oxide (ZnO), (b) synthesised zinc 543 
oxide – graphene oxide hybrid (ZnOGO). 544 
  545 
 546 
a) b)  547 
c)  d)  548 
Fig. 6 SEM images demonstrating the morphology and particle sizes of a) graphite, b) graphene oxide 549 
(GO), c) zinc oxide – graphene oxide hybrid (ZnOGO) and d) silver – graphene oxide hybrid (AgGO). 550 
  551 
 552 
 553 
Fig. 7 Zone of inhibition measurements demonstrating the antimicrobial efficacy of the compounds. 554 
The silver – graphene oxide hybrid (AgGO) was determined to be the most effective antimicrobial 555 
using this method. K. pneumoniae and E. faecium did not demonstrate inhibition by the compounds 556 
using this method. 557 
 558 
  559 
560 
 561 
Fig. 8 a) MIC and b) MBC of compounds against the four medically relevant bacteria demonstrating 562 
that the silver – graphene oxide hybrid (AgGO) demonstrated the greatest inhibitory and bactericidal 563 
effect.  564 
  565 
Table 1 EDX analysis demonstrating the elemental analysis (% weight) of the compounds 566 
 


























N/A Not applicable for elemental analysis 567 
 568 
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1) GO Ag-GO 
C=O 1738 1728 -10 
C=C 1615 1586 -29 
C-OH 1356 1363 +7 








849 879 +30 
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Table 3 Minimum to maximum size range of the particles 573 
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ZnOGO  0.05 30.0 
AgGO 0.01 13.0 
 575 
 576 
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